ABSTRACT
The aim of the present study was to determine the association between the presence of Ascaris suum at fattening pig farms, using different serological methods and the percentage of affected livers at slaughter, with performance and management indices. In total, 21 fattening pig farms from the North of Spain were included in the study. Serum samples were collected from pigs at slaughter and analysed for the presence of anti-Ascaris antibodies. For this, two different ELISAs were used. The first was based on the antibody recognition of the A. suum haemoglobin (As-Hb) molecule whereas the second test used the total extract of A. suum lung stage L3. The serological results were subsequently correlated with the percentage of condemned livers at slaughter, management practices and technical performance parameters including average daily gain (ADG) and feed conversion ratio (FCR). According to the data from the slaughterhouse, 12 out of the 21 farms had livers condemned due to liver white spots. A total of 10 farms (48%) had an average optical density ratio (ODr) exceeding the test cutoff when the As-Hb ELISA was used. This number increased to 18 farms (81%) when using the As-Lung-L3 ELISA. The average ODr of the farms on both ELISAs correlated positively with the percentage of affected livers (P<0.01). Only the average ODr values obtained with the As-Lung-L3 ELISA were positively correlated with the FCR (P<0.01). No correlation was found between percentage of affected livers or serology and the ADG. In relation to management practices, farms with greater than or equal to 50% slatted flooring and that applied the 'all-in/all-out' flow system showed a lower percentage of liver condemnations (P<0.01), lower average ODr results on the As-Lung-L3 ELISA (P<0.05) and lower FCR (P<0.01) compared with those with less than 50% slatted flooring. This study emphasizes that serology is a promising diagnostic tool for diagnosing ascariasis at fattening pig farms. It also supports earlier findings that the presence of A. suum can have a significant negative impact on farm productivity and that stable infrastructure or management practices can have a considerable impact on the control of this parasite.
Subject(s)
Ascariasis/veterinary , Ascaris suum/isolation & purification , Liver Diseases/veterinary , Swine Diseases/epidemiology , Abattoirs , Animals , Ascariasis/epidemiology , Ascariasis/parasitology , Enzyme-Linked Immunosorbent Assay/veterinary , Liver/parasitology , Liver Diseases/epidemiology , Liver Diseases/parasitology , Prevalence , Spain/epidemiology , Swine , Swine Diseases/parasitologyABSTRACT
The objective of this study was to evaluate the status of anthelmintic resistance (AR) in ruminants and horses in Spain. The efficacy of commonly used macrocyclic lactones (MLs) - ivermectin (IVM) and moxidectin (MOX) - was measured in sheep, cattle and horses. In addition, albendazole (ABZ) and levamisole (LEV) were evaluated in sheep and oxibendazole (OXI) and pyrantel (PYR) in horses. Efficacy was evaluated based on the difference between the arithmetic mean pre- and post-treatment faecal egg count (in cattle and horses), or compared to an untreated control group (in sheep). AR was present when the percentage reduction in egg count was <95% and the lower 95% confidence interval (CI) was <90%; if only one of these two criteria was met, the finding was recorded as suspected AR (SAR). In horses, AR-PYR and OXI was considered when the percentage reduction in egg count was ≤ 90% and the lower 95% CI was ≤ 80%. For each animal species, at least 10 study sites were selected. AR to at least one of the drugs was detected in all 10 sheep flocks; the main parasite identified after treatment was Teladorsagia circumcincta. Moreover, in 5 flocks multidrug resistance was identified, on 4 farms to drugs from different families, on one farm to both MOX and IVM and on another farm to all drugs tested. In cattle, the efficacy of both MOX and IVM was 100% on 4 and 3 farms, respectively, and therefore 60% of these farms were considered to have AR or SAR to both MLs. The most frequent parasite identified after treatment was Trichostrongylus spp., although Ostertagia ostertagi was also identified after treatment on one farm. In contrast to ruminants, the 4 drugs evaluated in horses were highly efficacious against strongyles, with efficacies for the MLs and OXI between 95 and 100% and between 94 and 100% for PYR, although 3 herds were SAR against PYR. In conclusion, AR to at least one of the commonly used drugs was identified on all sheep flocks investigated in the northwest of Spain. The occurrence of AR to MLs in cattle was higher than expected but consistent with what was observed in sheep. In horses, all currently used drugs were confirmed as effective against strongyles.
Subject(s)
Anthelmintics/pharmacology , Cattle Diseases/parasitology , Horse Diseases/parasitology , Nematoda/drug effects , Nematode Infections/veterinary , Sheep Diseases/parasitology , Animals , Cattle , Drug Resistance , Horse Diseases/epidemiology , Horses , Nematode Infections/epidemiology , Nematode Infections/parasitology , Sheep , Sheep Diseases/epidemiology , Spain/epidemiologyABSTRACT
Inter-simple sequence repeats markers were used to determinate the genetic variability of Fasciola hepatica populations recovered from sheep and cattle from Spain (Sp1, Sp2, Sp3 and Sp4), UK (Eng), Ireland (Ir) and Mexico (Mex). Twenty five primers were tested but only five produced 39 reproducible bands, being 71.79% polymorphic bands. This percentage ranged from 10.26% in Sp4 to 48.72% in Sp1, and per host between 28.21 and 48.72% in sheep and between 10.26 and 38.46% in cattle. This relatively low range of genetic diversity within populations, with a mean of 34.40%, implies that a large proportion of variation resided among populations. The population differentiation (Gst = 0.547) indicated that 54.7% of variation is due to differences between populations and 45.3% due to differences within population. The Nei's distance ranged between 0.091 and 0.230 in sheep and between 0.150 and 0.337 in cattle. The genetic relationships between populations and individuals were shown by a UPGMA dendrogram and a principal coordinate analysis; both grouped all populations separately from Sp4, a population of from the Midwest of Spain with the lowest level of diversity. Small genetic distances were observed between Eng and Ir, on the one hand, and Sp1, Sp2, Sp3, from the Northwest of Spain, together with Mex, on the other.
Subject(s)
Cattle Diseases/parasitology , Fasciola hepatica/genetics , Fascioliasis/veterinary , Genetic Variation , Sheep Diseases/parasitology , Animals , Cattle , Cattle Diseases/epidemiology , DNA Primers/genetics , Fasciola hepatica/classification , Fascioliasis/epidemiology , Fascioliasis/parasitology , Genetic Markers , Ireland/epidemiology , Liver/parasitology , Mexico/epidemiology , Polymerase Chain Reaction/methods , Polymerase Chain Reaction/veterinary , Sheep , Sheep Diseases/epidemiology , Spain/epidemiology , United Kingdom/epidemiologyABSTRACT
The effects of the lipopolysaccharide (LPS) from Ochrobactrum intermedium in sheep with fasciolosis was reported previously, resulting in lower fecal egg counts and fluke burden. In the current study, we analyzed its immunological effects in two groups of sheep, treated (T) and controls (C). Fasciolosis induces a T helper (Th) type-2 response, characterized by IL-4 and IL-10 production; however, at the beginning of the infection, the IFN-γ production predominates (Th type-1 response). Although we did not find differences in IL-4 production or in the expression level of this gene in the hepatic lymph nodes, the expression level of IL-10 was higher (P < 0.05) in the T group at 4 wpi. The IFN-γ production was higher (P < 0.01) at 12 wpi as well as its level of expression at 4 wpi (P < 0.05) in the T group. We found a higher expression level of TGF-ß at 4 wpi in the T group (P < 0.05), associated with the previous report of thicker fibrous tracks in a treated group. Immunoglobulin G1, related with a Th type-2 response, was higher (P < 0.01) in the T group at 4 and 12 wpi. In conclusion, the effects of LPS from O. intermedium could have resulted from a predominant Th type-2 immune response.
Subject(s)
Fasciola hepatica/immunology , Fascioliasis/veterinary , Lipopolysaccharides/pharmacology , Ochrobactrum/metabolism , Sheep Diseases/immunology , Sheep/immunology , Sheep/parasitology , Animals , Fascioliasis/immunology , Fascioliasis/metabolism , Feces/parasitology , Immunoglobulin G/metabolism , Interferon-gamma/metabolism , Interleukin-10/metabolism , Interleukin-4/metabolism , Lipopolysaccharides/metabolism , Sheep Diseases/metabolism , Sheep Diseases/pathology , Th2 Cells/drug effects , Th2 Cells/pathology , Transforming Growth Factor beta/metabolismABSTRACT
The effects of two diets supplemented with flaxseed oil (FO) or vitamin E (VE) were studied in sheep infected with Fasciola hepatica. The control group (CO), not supplemented, had higher weight gain and faecal egg count (P < 0.05) at the end of the study. At necropsy, the number (71.2 ± 26.5) and size of flukes were lower in the FO group (P < 0.01), probably due to the higher levels of white blood cells and lymphocytes (P < 0.01). This group also had higher red blood cell and haematocrit values (P < 0.01). The CO group had more severe hypoproteinaemia and hypoalbuminaemia, due to having the highest fluke burden (123.0 ± 35.2), and also the highest IgG1 titre (P < 0.01). The diet did not affect production or gene expression levels of IFN-γ and IL-4. On the other hand, the supplementation with VE led to a reduction in adult fluke burden (97.7 ± 39.9) and lower lipid oxidation in the liver (P < 0.001).
Subject(s)
Fasciola hepatica/drug effects , Fascioliasis/veterinary , Linseed Oil/administration & dosage , Sheep Diseases/diet therapy , Sheep Diseases/parasitology , Vitamin E/administration & dosage , Analysis of Variance , Animals , Body Constitution/drug effects , Body Weight/drug effects , DNA Primers/genetics , Dietary Supplements , Fascioliasis/blood , Fascioliasis/diet therapy , Feces/parasitology , Immunoglobulin G/blood , Interferon-gamma/metabolism , Interleukin-4/metabolism , Lipid Peroxidation/drug effects , Male , Parasite Egg Count/veterinary , Real-Time Polymerase Chain Reaction , Sheep , Sheep Diseases/blood , Sheep, Domestic , Thiobarbituric Acid Reactive SubstancesABSTRACT
The aim of this study was to develop an egg hatch assay (EHA) to detect the resistance of Fasciola hepatica to albendazole (ABZ). With this purpose, two different F. hepatica isolates were tested: (i) susceptible (Shrewsbury/South Gloucester strain) to ABZ (SA); (ii) resistant to ABZ (RA). A commercial formulation of ABZ (Sinvermin) diluted in dimethyl sulfoxide (DMSO) was used at concentrations of 0.0002, 0.002, 0.02, 0.2, and 2 µg/ml. In the SA isolates, eggs from feces exposed to ABZ at the three highest concentrations showed significantly lower hatching percentages than the control well (P<0.01); also for the two highest concentrations, the percentage of development was significantly lower than the control (P<0.01). However, in the RA isolate, no differences among treatments and control were found in the percentage of hatched or developed eggs. On the other hand, the EHA was conducted over a 15 day period following treatment with ABZ for sheep infected by the RA isolate. On day 7 post-treatment (pt), no differences among treatments and controls were observed. On day 15 pt, the development and hatching rates exposed to the highest ABZ concentration were lower than at lower concentrations, suggesting susceptibility. The ovicidal effect of ABZ and the potential use of EHA to differentiate between ABZ susceptible and resistant isolates are confirmed in the current study. However, the use of this technique should be confirmed with a higher number of isolates.
Subject(s)
Albendazole/pharmacology , Anthelmintics/pharmacology , Drug Resistance , Fasciola hepatica/drug effects , Fascioliasis/veterinary , Parasitology/methods , Sheep Diseases/parasitology , Albendazole/therapeutic use , Animals , Anthelmintics/therapeutic use , Fascioliasis/drug therapy , Fascioliasis/parasitology , Feces/parasitology , Ovum/drug effects , Sheep , Sheep Diseases/drug therapyABSTRACT
The effects of the lipopolysaccharide (LPS) from Ochrobactrum intermedium was evaluated in sheep experimentally infected with Fasciola hepatica. Animals were divided into four groups: two treated with the LPS (T1/T2) and two controls (C1/C2). T1/C1 were slaughtered at 30 days postinfection (dpi) and T2/C2 at 85 dpi. Body weight and body condition were found higher in T1 and T2 than in controls, although differences were not significant. Treated sheep showed lower cumulative fecal egg count than controls (p < 0.01). Levels of red blood cells (RBC), white blood cells, hemoglobin, and hematocrit (HCT) were higher in T1 and T2. Significant differences (p < 0.05) in RBC and HCT were found between groups at 84 dpi. More severe macrocytic and hypochromic anemia was observed in C1 and C2 than in treated groups. Total protein and albumin values were higher in T1 and T2 (p < 0.01) until 29 dpi. At the end of the trial, no significant differences were observed in hepatic enzymes, although gamma-glutamyl transferase and aspartate aminotransferase values were higher in C2, and alanine aminotransferase was higher in T2. At necropsy, the mean weight of liver, fibrosis in portal triads, and ganglion size were similar in all groups. The number and size of flukes was greater in C2 than in T2 (p < 0.05). The histological examinations revealed a higher degree of parenchymatous fibrosis in T2 compared to C2 (p < 0.05). The administration of LPS from O. intermedium increased the nonspecific resistance against F. hepatica in experimentally infected sheep.
Subject(s)
Fasciola hepatica/immunology , Fascioliasis/veterinary , Immunologic Factors/pharmacology , Lipopolysaccharides/pharmacology , Ochrobactrum , Sheep Diseases/parasitology , Animals , Fascioliasis/drug therapy , Fascioliasis/parasitology , Immunomodulation/immunology , Sheep , Sheep Diseases/drug therapyABSTRACT
The aim of this study was to develop a PCR for the diagnosis of Fasciola hepatica infection in feces of sheep based on the ribosomal internal transcribed spacer. Detection of infection was possible from the second week post-infection in experimentally infected sheep by amplification of a 292bp fragment. This PCR was employed for the detection of anthelmintic resistance (AR) in naturally infected sheep flocks, and results were compared with techniques such as the fecal egg count reduction test (FECRT) and the copro-antigen reduction test (CRT). The FECRT was carried out in two flocks, Santillan de la Vega (SV) and Corullón (CR), with sheep treated with albendazole (ABZ), clorsulon (CL), or triclabendazole (TCBZ). Feces were collected from individuals on days 0, 7, 15, and 30 post-treatment (pt). The FECRT showed adult F. hepatica to be resistant to ABZ and CL in both flocks. All parasite stages in the SV flock were susceptible to TCBZ, while in the CR flock, adult flukes showed resistance and immature forms were susceptible to the treatment. To compare FECRT and the PCR results, we calculated the percent of positive sheep on day 1 pt. In both flocks, the percent positive sheep was consistently higher by PCR than by sedimentation, confirming that the PCR is a more sensitive method of diagnosing infection and therefore to detect the resistance in infected animals. The CRT was carried out in the SV flock using a sandwich ELISA kit. The percent of sheep found positive by PCR was higher than with ELISA. Comparison of FECRT, CRT, and PCR for the detection of AR showed PCR to be the most sensitive.
Subject(s)
Anthelmintics/pharmacology , Drug Resistance , Fascioliasis/veterinary , Feces/parasitology , Polymerase Chain Reaction/veterinary , Sheep Diseases/parasitology , Animals , Fasciola hepatica/drug effects , Fascioliasis/diagnosis , Fascioliasis/parasitology , Parasite Egg Count , Polymerase Chain Reaction/methods , Sheep , Sheep Diseases/diagnosisABSTRACT
The aim of this study was to update the anthelmintic resistance (AR) status in sheep flocks infected by gastrointestinal nematodes (GIN) by means of in vivo and in vitro methods in the northwest of Spain. With this objective, we studied the efficacy of benzimidazoles (BZs), imidazothiazoles (IMs) and macrocyclic lactones (MLs), between 2006 and 2011. The sampling area was the Autonomous Community of Castilla y León but the majority of the flocks were located in the province of León. When the mean of GIN eggs per gram (epg) in faeces in a flock was higher than 150, the in vivo Faecal Egg Count Reduction Test (FECRT) was carried out. According to this test, AR was present in 63.6% of flocks, independently of the anthelmintic used. Flocks were mainly resistant to levamisole (LEV) (59.0%), followed by ivermectin (IVM) (27.3%) and albendazole (13.6%). Multidrug-resistance was also observed in 27.2% of the flocks, one of them being resistant to all anthelmintic families, including long-acting moxidectin. Comparing the evolution of AR in the last decade, between 1999 and 2011, the level of resistance to BZs and MLs was fairly constant throughout the time by means of the FECRT. However, the resistance to LEV increased significantly in only one decade since during the period 1999-2003 the percentage was 38.5%. The AR status was also measured by in vitro techniques in those flocks with an egg output lower than 150 epg. The prevalence of AR to BZs reached the 35.3% by Egg Hatch Assay. However, the level of resistance reported for LEV and IVM was 61.5% and 23.5%, respectively, by using the Larval Feeding Inhibition Assay, percentages very similar to those reported with the FECRT.
Subject(s)
Anthelmintics/pharmacology , Anthelmintics/therapeutic use , Drug Resistance , Gastrointestinal Diseases/veterinary , Nematoda/drug effects , Nematode Infections/veterinary , Sheep Diseases/drug therapy , Animals , Drug Resistance, Multiple , Feces/parasitology , Gastrointestinal Diseases/drug therapy , Nematode Infections/drug therapy , SheepABSTRACT
The aim of this study was to compare three different techniques for the early diagnosis of the infection by Fasciola hepatica in experimentally and naturally infected sheep. The experimental group consisted of 7 sheep infected with 200 metacercariae; faecal samples were taken weekly until 12 week post-infection (wpi). Under natural conditions, 45 individual faecal samples and 2 pools of faeces were collected from three different flocks with a history of F. hepatica infection. The results obtained by a coprological method were compared with a commercial immunoassay and with two PCR assays in faecal samples. Faecal eggs were detected by 9 wpi in experimental infection. On the other hand, only 24 out of 45 sheep were positive in naturally infected flocks. By means of a sandwich-ELISA kit, the infection was first detected by 4 wpi in the 57.1% experimentally infected sheep and this percentage reached 100% by 8 wpi. All naturally infected animals were positive with this method. Regarding PCR, a specific 423 bp fragment of mitochondrial DNA was amplified in faecal samples. The F. hepatica infection was detected from 3 wpi with a standard PCR, and from 2 wpi with a nested-PCR. Only 37 sheep out of 45 were positive by the standard PCR although the infection was diagnosed in all animals by the nested-PCR. In conclusion, the sensitivity of the nested-PCR described in our study is higher than the detection of eggs in faeces as well as the commercial immunoassay. Moreover, no cross reactions were described with gastrointestinal nematodes.
Subject(s)
Antigens, Helminth/isolation & purification , DNA, Helminth/isolation & purification , Fasciola hepatica/isolation & purification , Fascioliasis/veterinary , Sheep Diseases/diagnosis , Animals , Antibodies, Helminth/immunology , Antigens, Helminth/immunology , Base Sequence , DNA, Helminth/chemistry , DNA, Mitochondrial/isolation & purification , Enzyme-Linked Immunosorbent Assay/veterinary , Fasciola hepatica/genetics , Fasciola hepatica/immunology , Fascioliasis/diagnosis , Fascioliasis/immunology , Fascioliasis/parasitology , Feces/parasitology , Female , Molecular Sequence Data , Parasite Egg Count/veterinary , Polymerase Chain Reaction/veterinary , Sensitivity and Specificity , Sequence Alignment , Sequence Analysis, DNA , Sheep , Sheep Diseases/immunology , Sheep Diseases/parasitologyABSTRACT
Objetivos: Valorar la importancia de las modificaciones que aparecen en el citoesqueleto celular (en particular a nivel de unos filamentos intermedios denominados queratinas) a lo largo de los cambios que sufre la glándula mamaria, con especial referencia a la lactación. Su expresión será diferente y servirá como método de contraste. Diseño: 40 ratones distribuidos en cinco grupos según la etapa de estudio. El esquema experimental es común para todos ellos. Material y métodos: Análisis inmunohistoquímico de las muestras procedentes de las glándulas mamarias para evidenciar modificaciones a nivel de las citoqueratinas y comparación con otros estudios en diferentes modelos animales. Resultados: Cada citoqueratina presenta una expresión diferente según sea la estirpe celular y el periodo de lactación. Se diferencian mediante el uso de anticuerpos específicos marcados. Conclusiones: La expresión citoqueratínica varía de manera fisiológica y en células tumorales. La detección inmunohistoquímica de citoqueratinas puede servir como método de diagnóstico complementario (AU)
Objectives: To assess the importance of the changes that appear into the cytoskeleton (especially referred to some specific intermediate filaments called keratins) through different stages the mammary gland bears, focusing on the lactation. Their expression will be different in pathological conditions and this will be useful for contrasting other procedures. Design: 40 mice distributed into five groups according to the tage of study. The experimental project is the same for everyone. Material and methods: Immunohistochemical analysis from samples obtained from mammary glands in order to show changes into cytokeratin expression and comparison with other researches in different animal models. Results: The expression of every cytokeratin is different according to the cell lineage and the lactation period. Specific antibodies can reveal it. Conclusions: The cytokeratinic pattern changes in a physiological sense and also in malignant processes. Immunohistochemical detection of cytokeratins may be useful as complementary diagnosis (AU)